Exenatide improves cisplatin induced ovarian damage through NLRP3, Nrf-2, and TLR4 pathways
- 2025, Volume 93 - Number 1
- Published: October 9, 2024
Exenatide improves cisplatin induced ovarian damage through NLRP3, Nrf-2, and TLR4 pathways
Gül O. Doğan 1, Oytun Erbaş 2
1 Department of Gynecology and Obstetrics, ??i??li Hamidiye Eftal Hospital, Istanbul, Turkey; 2 Department of Physiology, Demiro??lu Bilim University Medical School, Istanbul, Turkey
Gül O. Doğan, Oytun Erbaş
La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.
*Correspondence: Gül O. Doğan, Email not available
Abstract
Full content available in the PDF
Keywords: Cisplatin. Exenatide. Ovarian. Toxicity.
